Groundbreaking research demonstrates how Nanoscope’s synthetic opsin restores vision in patients with severe retinal degeneration DALLAS, March 24, 2025 /PRNewswire/ — Researchers with Nanoscope Therapeutics Inc., a biotechnology company committed to restoring vision in blind patients in…